《癌症研究与治疗学杂志》(Journal Of Cancer Research And Therapeutics)是一本以ONCOLOGY综合研究为特色的国际期刊。该刊由Wolters Kluwer Medknow Publications出版商创刊于2005年,刊期Quarterly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦ONCOLOGY领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为...
影响因子(2023) 1.563The journal will cover technical and clinical studies related to health, ethical and social issues in field of Medical oncology, radiation oncology, medical imaging, radiation protection, non-ionising radiation, radiobiology. Articles with clinical interest and implications will be gi...
影响因子:1.4 年发文量:434 出版商:Wolters Kluwer Medknow Publications 平均审稿速度: 约6月 期刊发表咨询作者投稿咨询 期刊简介中科院分区JCR分区CiteScore其它数据发文统计投稿提示 Journal Of Cancer Research And Therapeutics期刊简介 The journal will cover technical and clinical studies related to health, ethica...
IF影响因子 自引率7.80% 主要研究方向医学-ONCOLOGY 肿瘤学 Journal of Cancer Research and Therapeutics《癌症研究与治疗杂志》(一年7期). The journal will cover technical and clinical studies related to health, ...[显示全部] 给编辑部投稿--> 官网投稿 收藏本刊 报刊点评 咨询编辑部 纠错、补充 ...
IF影响因子 1.4 是否预警 否 投稿咨询投稿指南 期刊简介 Journal Title:Journal Of Cancer Research And Therapeutics The journal will cover technical and clinical studies related to health, ethical and social issues in field of Medical oncology, radiation oncology, medical imaging, radiation protection, non...
human tumour cell lines to demonstrate the generality of the results obtained, and where appropriate studies should be extended to investigate the putative molecular target of the agent(s) and the relationship between drug-target interaction and phenotypic effects such as cell growth inhibition or apop...
影响因子:是美国科学信息研究所(ISI)的期刊引证报告(JCR)中的一项数据。指的是某一期刊的文章在特定年份或时期被引用的频率,是衡量学术期刊影响力的一个重要指标。自1975年以来,每年定期发布于“期刊引证报告”(JCR)。 发文统计(统计区间:2023年-2024年) ...
and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and ...
The mission of the journal is to communicate advances in fields including biotherapy, targeted drug and radionuclide delivery, nanotechnology, and studies that advance the understanding of the mechanism of action and response of cancer to therapeutics. It is the expectation of this journal that all ...
Scientific topics include: biochemistry; chemical, physical, and viral carcinogenesis and mutagenesis; clinical investigations including clinical trials; endocrinology; epidemiology and prevention; experimental therapeutics; immunology and immunotherapy including biological therapy; molecular biology and genetics; ...